Morana Jovan-Embiricos
CIK 1575745 · last filed 2026-06-04
Morana Jovan-Embiricos is a corporate insider who has filed 23 SEC Form 4 insider transactions across 5 companies since 2014. The most recent filing, for KLRS, was dated Jun 4, 2026. Across all open-market trades the lifetime net is +$37.5M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $7.9M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$7.92M
5
23
$37.47M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KLRS | Director | — | $4.33 | — | $0 | 2 | 2026-06-04 |
| Kalaris Therapeutics, Inc. (ALVR) Delisted | Director | 967,875 | $9.81 | $9.49M | $48.59M | 11 | 2024-06-07 |
| CGEM | Director | 578,214 | $13.70 | $7.92M | -$10.70M | 4 | 2022-06-28 |
| TCR2 THERAPEUTICS INC. (TCRR) Delisted | 10%+ Owner | 90,026 | $1.48 | $133.2K | -$412.5K | 1 | 2019-10-24 |
| Radius Health, Inc. (RDUS) Delisted | Director | 0 | $30.00 | $0 | $0 | 5 | 2015-01-20 |
Recent Filings
23 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-04 | KLRS | Grant (A) | — | $0 | EDGAR |
| 2025-04-11 | KLRS | Grant (A) | — | $0 | EDGAR |
| 2024-06-07 | Kalaris Therapeutics, Inc. (ALVR) Delisted | Grant (A) | +35,000 | $0 | EDGAR |
| 2023-05-12 | Kalaris Therapeutics, Inc. (ALVR) Delisted | Grant (A) | +35,000 | $0 | EDGAR |
| 2022-08-01 | Kalaris Therapeutics, Inc. (ALVR) Delisted | Grant (A) | +8,152,247 | $37.58M | EDGAR |
| 2022-06-28 | CGEM | Mixed | +95,296 | $14 | EDGAR |
| 2022-06-23 | CGEM | Sell (S) | −203,806 | -$2.61M | EDGAR |
| 2022-05-19 | Kalaris Therapeutics, Inc. (ALVR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-05-16 | CGEM | Sell (S) | −837,476 | -$8.09M | EDGAR |
| 2022-03-25 | CGEM | Grant (A) | — | $0 | EDGAR |